Mangoceuticals, Inc. (NASDAQ:MGRX)
| Market Cap | $2.75M-89.3% |
| Revenue (ttm) | $300.48K-35.6% |
| Net Income | -$11.04M+44.3% |
| EPS | -$0.67+76.6% |
| Shares Out | 22.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 241,271 |
| Open | $0.13 |
| Previous Close | $0.13 |
| Day's Range | $0.12 - $0.14 |
| 52-Week Range | $0.12 - $1.38 |
| Beta | 2.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MGRX
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MGRX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MGRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MGRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MGRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MGRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MGRX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MGRX
| VXFVanguard Extended Market ETF | $28.72K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from MGRX’s recent data — informational, not investment advice
